Merck (MRK) Minority Interest (2009 - 2026)

Merck (MRK) has 18 years of Minority Interest data on file, last reported at $53.0 million in Q1 2026.

• Minority Interest for Q1 2026 came in at $53.0 million, down 18.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $53.0 million (down 18.46% YoY), and the FY2025 annual result was $56.0 million, down 5.08% from the prior year.
• Minority Interest fell to $53.0 million in Q1 2026 per MRK's latest filing, from $56.0 million in the prior quarter.
• Over five years, Minority Interest peaked at $75.0 million in Q2 2022 and troughed at $49.0 million in Q2 2023.
• A 5-year average of $61.6 million and a median of $60.0 million in 2024 frame the typical range for Minority Interest.
• The sharpest annual moves came in 2023 and 2024: Minority Interest sank 34.67% in 2023, then soared 34.69% in 2024.
• A 5-year view of Minority Interest shows it stood at $67.0 million in 2022, then dropped by 19.4% to $54.0 million in 2023, then rose by 9.26% to $59.0 million in 2024, then dropped by 5.08% to $56.0 million in 2025, then dropped by 5.36% to $53.0 million in 2026.
• Business Quant data shows MRK's Minority Interest at $53.0 million in Q1 2026, $56.0 million in Q4 2025, and $57.0 million in Q3 2025.